{
    "clinical_study": {
        "@rank": "136006", 
        "arm_group": [
            {
                "arm_group_label": "Ibuprofen", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Oral morphine", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "Children 5-17 years of age who have sustained a non-operative distal forearm (radius and/or\n      ulna) or clavicular fracture will be randomized to receive either ibuprofen or oral morphine\n      as needed for pain relief for the first 24 hours following discharge from the emergency\n      department. Pain will be assessed using the self-report Faces pain scale revised (FPS-R).\n      We hypothesize that oral morphine will result in greater pain relief than ibuprofen."
        }, 
        "brief_title": "Oral Morphine Versus Ibuprofen", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Upper Extremity Fractures", 
            "Analgesia Post Fracture"
        ], 
        "condition_browse": {
            "mesh_term": "Fractures, Bone"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Exclusion Criteria:\n\n          -  patients with known hypersensitivity to either ibuprofen or morphine\n\n          -  chronic users of NSAIDS or opioids\n\n          -  fractures requiring operative management\n\n          -  associated injuries requiring analgesia\n\n          -  poor English fluency\n\n          -  pregnancy\n\n        Inclusion Criteria:\n\n          -  All patients aged 5 to 17 years with a non-operative forearm or distal radius\n             fracture"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "17 Years", 
            "minimum_age": "5 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01690780", 
            "org_study_id": "R-11-340", 
            "secondary_id": "18091"
        }, 
        "intervention": [
            {
                "arm_group_label": "Oral morphine", 
                "description": "oral morphine 0.5 mg/kg (max 10 mg) every 6 hours as needed for 24 hours", 
                "intervention_name": "Oral morphine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Ibuprofen", 
                "description": "Ibuprofen 10 mg/kg (max 600 mg) every 6 hours as needed for pain (maximum 4 doses) for 24 hours following discharge from the emergency department", 
                "intervention_name": "Ibuprofen", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ibuprofen", 
                "Morphine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "fracture", 
            "pediatric", 
            "oral morphine", 
            "ibuprofen"
        ], 
        "lastchanged_date": "September 19, 2012", 
        "location": {
            "contact": {
                "email": "poonai@hotmail.com", 
                "last_name": "Naveen P Poonai, MD", 
                "phone": "519 685 8500", 
                "phone_ext": "52011"
            }, 
            "contact_backup": {
                "email": "rod.lim@lhsc.on.ca", 
                "last_name": "Rod Lim, MD", 
                "phone": "519 685 8500", 
                "phone_ext": "52011"
            }, 
            "facility": {
                "address": {
                    "city": "London", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "N6A5W9"
                }, 
                "name": "London Health Sciences Center"
            }, 
            "investigator": {
                "last_name": "Naveen P Poonai, MD MSc FRCPC", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Oral Morphine Versus Ibuprofen for Post-fracture Pain Management in Children: a Randomized Controlled Study", 
        "overall_official": {
            "affiliation": "Lawson Health Research Institute", 
            "last_name": "Naveen Poonai, MD, FRCPC", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome variable is the pre-post intervention difference in pain scores as measured by self-reported Faces Pain Scale - Revised (FPS-R) for the first 24 hours post-fracture management following the as needed administration of the study drugs.", 
            "measure": "Faces Pain scale - revised", 
            "safety_issue": "No", 
            "time_frame": "30 minutes post intervention compared to baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01690780"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Lawson Health Research Institute", 
            "investigator_full_name": "Naveen Poonai", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "The secondary outcome variable is the number of breakthrough acetaminophen doses required/taken by the participant for the first 24 hours post-fracture management", 
            "measure": "Acetaminophen doses", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "source": "Lawson Health Research Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Naveen Poonai", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}